Genesis Financial Group LLC Takes Position in Planet Labs PBC $PL

Genesis Financial Group LLC bought a new position in shares of Planet Labs PBC (NYSE:PL) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 22,500 shares of the company’s stock, valued at approximately $444,000.

Several other large investors have also recently bought and sold shares of PL. Barclays PLC lifted its holdings in Planet Labs PBC by 758.1% during the 3rd quarter. Barclays PLC now owns 3,727,743 shares of the company’s stock worth $48,386,000 after buying an additional 3,293,333 shares during the last quarter. Invesco Ltd. increased its holdings in shares of Planet Labs PBC by 265.6% in the 3rd quarter. Invesco Ltd. now owns 3,450,479 shares of the company’s stock valued at $44,787,000 after acquiring an additional 2,506,595 shares during the last quarter. Two Sigma Investments LP increased its holdings in shares of Planet Labs PBC by 257.5% in the 3rd quarter. Two Sigma Investments LP now owns 2,362,275 shares of the company’s stock valued at $30,662,000 after acquiring an additional 1,701,535 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Planet Labs PBC by 9.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,551,697 shares of the company’s stock worth $240,801,000 after acquiring an additional 1,637,880 shares in the last quarter. Finally, Marshall Wace LLP raised its position in shares of Planet Labs PBC by 10,305.7% during the 2nd quarter. Marshall Wace LLP now owns 1,509,248 shares of the company’s stock worth $9,206,000 after acquiring an additional 1,494,744 shares in the last quarter. Hedge funds and other institutional investors own 41.71% of the company’s stock.

Planet Labs PBC Trading Up 16.7%

PL opened at $35.84 on Friday. The company has a quick ratio of 1.64, a current ratio of 1.65 and a debt-to-equity ratio of 2.37. Planet Labs PBC has a 52 week low of $2.79 and a 52 week high of $37.05. The business’s 50 day moving average is $26.03 and its two-hundred day moving average is $19.32. The firm has a market cap of $12.41 billion, a price-to-earnings ratio of -45.95 and a beta of 1.83.

Planet Labs PBC (NYSE:PL) last announced its earnings results on Thursday, March 19th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.43). The business had revenue of $86.82 million for the quarter, compared to analysts’ expectations of $78.17 million. Planet Labs PBC had a negative return on equity of 69.61% and a negative net margin of 80.22%.The business’s revenue was up 41.1% compared to the same quarter last year. On average, research analysts predict that Planet Labs PBC will post -0.37 EPS for the current year.

Wall Street Analyst Weigh In

PL has been the subject of a number of research analyst reports. Citigroup upped their price target on Planet Labs PBC from $30.00 to $35.00 and gave the company a “buy” rating in a report on Thursday. Zacks Research raised shares of Planet Labs PBC from a “strong sell” rating to a “hold” rating in a report on Friday, February 13th. Craig Hallum restated a “buy” rating and set a $30.00 price objective on shares of Planet Labs PBC in a research report on Tuesday, January 13th. Morgan Stanley upped their target price on shares of Planet Labs PBC from $26.00 to $35.00 and gave the company an “equal weight” rating in a report on Wednesday, March 25th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Planet Labs PBC from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Six investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $27.70.

Insider Buying and Selling

In other Planet Labs PBC news, CFO Ashley F. Johnson sold 150,731 shares of the company’s stock in a transaction on Wednesday, January 21st. The shares were sold at an average price of $27.01, for a total transaction of $4,071,244.31. Following the completion of the transaction, the chief financial officer owned 1,956,101 shares in the company, valued at approximately $52,834,288.01. This represents a 7.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kristen Robinson sold 47,835 shares of the firm’s stock in a transaction on Wednesday, January 21st. The stock was sold at an average price of $26.96, for a total transaction of $1,289,631.60. Following the completion of the sale, the director owned 222,897 shares of the company’s stock, valued at $6,009,303.12. This trade represents a 17.67% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 218,566 shares of company stock valued at $5,896,276 over the last three months. 17.53% of the stock is currently owned by company insiders.

Planet Labs PBC News Summary

Here are the key news stories impacting Planet Labs PBC this week:

• Positive Sentiment: Sector rally: Planet Labs jumped alongside other space stocks as investor appetite for the space theme increased ahead of the anticipated SpaceX IPO, helping push PL higher. Planet Labs (PL) Climbs 9.9% as Space Stocks Fly
• Positive Sentiment: Margin improvement: Analysts note margin expansion driven by a shift to subscription revenue, greater automation and vertical integration — factors that improve unit economics and make future profitability more credible. Planet Labs Margins Expand on Revenue Mix Shift, Automation?
• Positive Sentiment: Analyst support: Citi raised its price target to $35 and kept a buy rating, giving an additional catalyst for momentum and institutional interest. Benzinga coverage of Citi price target raise
• Neutral Sentiment: Volume and headlines: Heavy intraday volume and media coverage are amplifying short-term moves; this flow-driven effect can sustain momentum but may reverse if news flow cools. What’s going on with Planet Labs stock Thursday?
• Negative Sentiment: Valuation concerns: Some analysts warn PL trades at a steep premium despite strong growth and backlog, raising the risk that expectations are already priced in. Planet Labs Trades at a Premium: Should You Still Buy the Stock?
• Negative Sentiment: Profitability and fundamentals: Recent quarterly results showed an EPS miss and continued negative margins/ROE; while revenue is growing, profitability remains a headwind that could limit sustained upside until structural improvement is confirmed.

Planet Labs PBC Profile

Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.

Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.